4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-20-038879
Options or other derivatives
- SVP, Chief Scientific Officer acquired 31,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Abrahmsen Lars B. SVP, Chief Scientific Officer | 2020-03-24 | Grant or award · Stock Option (right to Buy) | +31,600 | 31,600 | D | ||
Loading xslF345X03/a4.xml…